Elastin and elastase-like enzyme change in aorta of rat with malignant hypertension.
In order to study the role of elastin in arteries with respect to hypertension and hypertensive arterial disease, aortic elastin content and elastase-like enzyme activity were examined and compared in stroke-prone spontaneously hypertensive rats (SHRSP), which show malignant hypertension, and Wistar-Kyoto normotensive rats (WKY). The elastin content was lower, whereas the elastase-like activity was higher at 20 weeks of age in SHRSP than in WKY, so that the aortic elastin/enzyme ratio of SHRSP was lower than that in WKY. These differences were not found at 6 weeks of age (prehypertensive stage). For SHRSP anti-hypertensive treatment resulted in lowering the elastase-like activity and in increasing the elastin content in comparison to untreated animals. The subcellular distribution of the elastase-like activity closely correlated with that of 5'-nucleotidase activity, a plasma membrane marker enzyme. The results indicate involvement of a smooth muscle plasmalemmal elastase-like enzyme in vascular connective tissue metabolism in health and possibly also its participation in hypertensive arterial diseases.
D000375:Aging; D000818:Animals; D001011:Aorta / Q000032:analysis* / Q000201:enzymology; D001794:Blood Pressure; D002462:Cell Membrane / Q000032:analysis / Q000201:enzymology; D004549:Elastin / Q000032:analysis*; D006830:Hydralazine / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D010196:Pancreatic Elastase / Q000378:metabolism*; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D012110:Reserpine / Q000627:therapeutic use
D006830:Hydralazine; D012110:Reserpine; D004549:Elastin; D010196:Pancreatic Elastase